Search Results

Landmark Studies

Questions and Answers on AGIS Statistics

Jeffrey Tennant, MD; Douglas E. Gaasterland, MD; E. Kenneth Sullivan, PhD; and Paul VanVeldhuisen, PhD

Landmark Studies

Questions and Answers on AGIS Statistics

Jeffrey Tennant, MD; Douglas E. Gaasterland, MD; E. Kenneth Sullivan, PhD; and Paul VanVeldhuisen, PhD

Peer Review

The Role of SPARC in Trabecular Meshwork Extracellular Matrix Turnover and IOP Regulation

Developing an understanding of this matricellular protein may reveal molecular targets for the therapeutic treatment of primary open-angle glaucoma.

Ayan Chatterjee, MS; Dong-Jin Oh, PhD; Min Hyung Kang, PhD; Guadalupe Villarreal, MD; Ramez Haddadin, MD; Marc Töteberg-Harms, MD; Swarup S. Swaminathan, MD; and Douglas J. Rhee, MD

Reconsidering Transscleral Cyclophotocoagulation

Introduction By Douglas E. Gaasterland, MD

Highlights of the AGS Annual Meeting

The latest research findings from the 21st annual meeting of the American Glaucoma Society.

GEOFFREY T. EMERICK, MD

Diode Laser Cyclophotocoagulation

Technique and results.

Douglas E. Gaasterland, MD

Diode Laser Cyclophotocoagulation

Technique and results.

Douglas E. Gaasterland, MD

Lessons From the AGIS

This study's findings are of practical importance to the clinician.

Douglas E. Gaasterland, MD

Lessons From the AGIS

This study's findings are of practical importance to the clinician.

Douglas E. Gaasterland, MD

The Implications of AGIS for Clinical Practice

Harry A. Quigley, MD, describes the insights offered by this study and the potential pitfalls involved in interpreting its results.

GILLIAN MCDERMOTT, EDITOR-IN-CHIEF

The Implications of AGIS for Clinical Practice

Harry A. Quigley, MD, describes the insights offered by this study and the potential pitfalls involved in interpreting its results.

GILLIAN MCDERMOTT, EDITOR-IN-CHIEF